Nurse Case Manager Model on Neuroblastoma Caregiver's Uncertainty (NCMM)

This study is currently recruiting participants.
Verified January 2012 by National Taiwan University Hospital
Sponsor:
Collaborators:
National Science Council, Taiwan
National Taiwan University
Information provided by (Responsible Party):
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT01525251
First received: January 30, 2012
Last updated: February 1, 2012
Last verified: January 2012

January 30, 2012
February 1, 2012
August 2009
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT01525251 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Nurse Case Manager Model on Neuroblastoma Caregiver's Uncertainty
The Effect of Nurse Case Manager Model on Caregiver's Adaptation of Disease Uncertainty About Their Child With Neuroblastoma

Clinical Problem and Significance: The incidence of neuroblastoma is about 30 cases a year in Taiwan. The five-year survival rate of neuroblastom is near 50% in Taiwan. Compared to the survival rate in Western countries, the treatment in Taiwan needs more efforts to improve. According to the report from the Childhood Cancer Foundation ROC, several children with neuroblastoma did not complete their treatment and or not received the protocol. In addition to the efforts in improving protocol, the reasons for those who drop-out and do not receive complete treatment need the investigators more attention to think of.

Purpose of Study: The main purpose is to evaluate the effects of nurse case manager model on caregivers' adaptation of disease uncertainty about then child with neuroblastorna.

Methods: A longitudinal and prospective design will be used to perform this study. Questionnaire survey and chart review will be the means of data collection for the part of quantative analysis. The qualitative method , semi-structural interview , also will be used to collect data regarding caregiver's perception of social support and adaptation at the same time of self-report of questionnaires survey .There are five points of time to collect data: Baseline (A), 3 months(B) , 6 months(C), 9 months(D),1 year(E) and 1.5 year(F) after eligible subjects agree to participate in the study.

Subjects: The study will use a convenience sample. Once the caregiver's child is on has been diagnosed with neuroblastoma will be recruited in this study.

Instruments: Three Chinese versions of Mishel Uncertainty in Illness-Parent Form , the self-reported socio-demographic questionnaire will be used to collect data. Process recording will be typed once finishing interview for further analysis.

Data Analysis: Quantitative data will be analyzed using SPSS 15.0 statistical software. The data will be analyzed using descriptive statistics and inferred statistics. Content analysis and theme formation will be categorized to assist the interpretation of quantitative results.

Implication: The findings of this study will be expected of the effects of nurse care manager model on children with newoblastoma cancer survivors.

Not Provided
Observational
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Caregiver of Neuroblastoma Childern

Neuroblastoma
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
60
Not Provided
Not Provided

Inclusion Criteria:

  • Care giver of Neuroblastoma Children

Exclusion Criteria:

  • NA
Both
Not Provided
No
Contact: Ya-Ling Lee, RN,DNSc +886-2-23123456 ext 88422 yallee@ntu.edu.tw
Contact: Hsiao-Ling Chen, RN,GC,MS +886-2-23123456 ext 88422 hsaolene@gmail.com
Taiwan
 
NCT01525251
200907067R
No
National Taiwan University Hospital
National Taiwan University Hospital
  • National Science Council, Taiwan
  • National Taiwan University
Principal Investigator: Ya-Ling Lee, RN,DNSc National Taiwan University
National Taiwan University Hospital
January 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP